{"title":"Research on the Cardiovascular Health of Women (Or the Lack Thereof)","authors":"Shelby L Sindelar","doi":"10.5070/M4122048566","DOIUrl":null,"url":null,"abstract":"Author(s): Sindelar, Shelby L | Abstract: Females are being inaccurately underrepresented in clinical studies of medications for cardiovascular disease. Even though about half of patients with cardiovascular disease in America are women, they only make up about 1/3 of the patients included in clinical studies for cardiac medications. Therefore, women needlessly experience negative side effects that could be prevented with cardiac medications specifically for women. Furthermore, females' hearts are fundamentally different than males' hearts and therefore, require different medications for their specific needs. Thus, pharmaceutical companies must develop cardiac medications tailored specifically for womens' hearts and biological needs in order to prevent unnecessary deaths due to underlying gender descrimination.","PeriodicalId":131320,"journal":{"name":"UC Merced Undergraduate Research Journal","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"UC Merced Undergraduate Research Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5070/M4122048566","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Author(s): Sindelar, Shelby L | Abstract: Females are being inaccurately underrepresented in clinical studies of medications for cardiovascular disease. Even though about half of patients with cardiovascular disease in America are women, they only make up about 1/3 of the patients included in clinical studies for cardiac medications. Therefore, women needlessly experience negative side effects that could be prevented with cardiac medications specifically for women. Furthermore, females' hearts are fundamentally different than males' hearts and therefore, require different medications for their specific needs. Thus, pharmaceutical companies must develop cardiac medications tailored specifically for womens' hearts and biological needs in order to prevent unnecessary deaths due to underlying gender descrimination.
作者:Sindelar, Shelby L |摘要:女性在心血管疾病药物的临床研究中被不准确地低估。尽管美国大约一半的心血管疾病患者是女性，但她们只占心脏药物临床研究中患者的三分之一左右。因此，女性不必要地经历负面的副作用，这些副作用可以通过专门针对女性的心脏药物来预防。此外，女性的心脏与男性的心脏根本不同，因此需要不同的药物来满足她们的特定需求。因此，制药公司必须开发专门针对妇女心脏和生理需要的心脏药物，以防止由于潜在的性别歧视造成不必要的死亡。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
